Magdalena Szopa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Magdalena Szopa has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Piotr Major
Department of Medical Education, Jagiellonian University Medical College, 31-008 Cracow, Poland
4 shared publications - Maciej Tadeusz Malecki
Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland
3 shared publications - Michal Kania
Chair of Metabolic Diseases, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
3 shared publications - Andrzej Budzyński
2nd Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland
2 shared publications - Hady Razak Hady
2nd Clinical Department of General, Gastroenterological and Oncological Surgery, Medical University of Bialystok, 15-089 Bialystok, Poland
2 shared publications - Jacek Szeliga
Department of General, Gastroenterological, and Oncological Surgery, Collegium Medicum Nicolaus Copernicus University, Torun, Poland
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (10) , e70308
The First Case of Digenic MODY Diabetes Involving Compound Heterozygosity of Three Variants in the PDX1 and HNF1B Genes
Objectives: We report a rare case of digenic MODY. In 2016, at age 15, the patient was diagnosed with type 1 diabetes and began insulin therapy. After discrepancies in her glycaemic control were observed, an extensive differential diagnosis was conducted. In 2024, genetic testing confirmed monogenic diabetes, allowing for tailored treatment of the patient. Methods and Results: The initial diagnosis was type 1 diabetes, later revised to MODY after Sanger screening. Genetic testing detected c.293C>T, p.Ala98Val in the HNF1A gene, which was initially misinterpreted as a variant causing Maturity Onset Diabetes of the Young (MODY), an autosomal dominant monogenic diabetes. Eventually, next‐generation sequencing (NGS) revealed three heterozygous variants in the MODY genes: HNF1B and PDX1 . The HNF1B and PDX1 genes are transcription factors responsible for pancreas development and insulin gene transcription. Two variants located very close to each other in the PDX1 gene were identified: c.694G>A, p.Gly232Ser and c.697G>T, p.Glu233Ter. The first causes an amino acid change, while the latter leads to an early termination codon. The third variant, c.827_828insT, p.Gly277ArgfsTer17, was found in the HNF1B gene, resulting in a premature STOP codon and a truncated nonsense protein product. This is the first report of a patient with a double MODY variant resulting in early protein termination. Overall, the available evidence suggests that all variants may be pathogenic. The variants' severity and likely digenic nature matched the proband's diabetes presentation, which didn't respond to oral agents and required insulin. Neither parent nor brother, each with a detected variant in a single gene, has developed diabetes. However, renal cysts were discovered in the mother and brother, and the father was diagnosed with prediabetes. Conclusions: This case highlights the severe presentation of likely digenic MODY, similar to type 1 diabetes. As NGS use increases, more patients like these are expected to be identified.
- 15 October 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (10) , e70308
Open AccessThe First Case of Digenic MODY Diabetes Involving Compound Heterozygosity of Three Variants in the PDX1 and HNF1B Genes
Objectives: We report a rare case of digenic MODY. In 2016, at age 15, the patient was diagnosed with type 1 diabetes and began insulin therapy. After discrepancies in her glycaemic control were observed, an extensive differential diagnosis was conducted. In 2024, genetic testing confirmed monogenic diabetes, allowing for tailored treatment of the patient. Methods and Results: The initial diagnosis was type 1 diabetes, later revised to MODY after Sanger screening. Genetic testing detected c.293C>T, p.Ala98Val in the HNF1A gene, which was initially misinterpreted as a variant causing Maturity Onset Diabetes of the Young (MODY), an autosomal dominant monogenic diabetes. Eventually, next‐generation sequencing (NGS) revealed three heterozygous variants in the MODY genes: HNF1B and PDX1 . The HNF1B and PDX1 genes are transcription factors responsible for pancreas development and insulin gene transcription. Two variants located very close to each other in the PDX1 gene were identified: c.694G>A, p.Gly232Ser and c.697G>T, p.Glu233Ter. The first causes an amino acid change, while the latter leads to an early termination codon. The third variant, c.827_828insT, p.Gly277ArgfsTer17, was found in the HNF1B gene, resulting in a premature STOP codon and a truncated nonsense protein product. This is the first report of a patient with a double MODY variant resulting in early protein termination. Overall, the available evidence suggests that all variants may be pathogenic. The variants' severity and likely digenic nature matched the proband's diabetes presentation, which didn't respond to oral agents and required insulin. Neither parent nor brother, each with a detected variant in a single gene, has developed diabetes. However, renal cysts were discovered in the mother and brother, and the father was diagnosed with prediabetes. Conclusions: This case highlights the severe presentation of likely digenic MODY, similar to type 1 diabetes. As NGS use increases, more patients like these are expected to be identified.
- Open Access
- 1 September 2026
- Published by Wiley in Journal of Internal Medicine
- Vol. 300 (6) , 725-742
European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy
Lipodystrophy comprises a heterogeneous group of disorders characterized by reduced adipose tissue often associated with severe metabolic complications. Lipodystrophy may be genetic, acquired, or secondary to medical therapies initiated for other conditions. Despite major advances in understanding adipose tissue biology and in human genetic technologies, diagnosis of lipodystrophy is still commonly delayed or missed. Conversely, increasing use of next‐generation sequencing has led to proliferation of proposed new genetic causes of lipodystrophy with variable supporting evidence. To address these challenges, an international expert working group from the European Consortium for Lipodystrophies first developed a consensus definition of lipodystrophy as deficient development and/or inadequate maintenance of adipose tissue not attributable to nutritional deprivation or a systemic catabolic state. Anatomical adipose deficiency alone is generally insufficient for diagnosis, with evidence of adipose tissue dysfunction or pathology also usually required. Building on this definition, a framework for evaluating candidate monogenic lipodystrophy syndromes is suggested, based on the strength of human phenotypic, genetic, and biological evidence. Primacy was assigned to direct evidence from affected individuals, with genetic and biological evidence considered supportive but not determinative. This approach accommodates both the variable penetrance and expressivity characteristic of many lipodystrophy syndromes and potential discrepancies between human observations and experimental models. Although the proposed definition is applicable across all forms of lipodystrophy, the classification system described here is restricted to monogenic disorders. Together, these tools aim to improve clinical recognition, promote diagnostic consistency, and provide a robust and adaptable framework for evaluating emerging gene–disease associations in lipodystrophy.
- 1 September 2026
- Published by Wiley in Journal of Internal Medicine
- Vol. 300 (6) , 725-742
Open AccessEuropean Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy
Lipodystrophy comprises a heterogeneous group of disorders characterized by reduced adipose tissue often associated with severe metabolic complications. Lipodystrophy may be genetic, acquired, or secondary to medical therapies initiated for other conditions. Despite major advances in understanding adipose tissue biology and in human genetic technologies, diagnosis of lipodystrophy is still commonly delayed or missed. Conversely, increasing use of next‐generation sequencing has led to proliferation of proposed new genetic causes of lipodystrophy with variable supporting evidence. To address these challenges, an international expert working group from the European Consortium for Lipodystrophies first developed a consensus definition of lipodystrophy as deficient development and/or inadequate maintenance of adipose tissue not attributable to nutritional deprivation or a systemic catabolic state. Anatomical adipose deficiency alone is generally insufficient for diagnosis, with evidence of adipose tissue dysfunction or pathology also usually required. Building on this definition, a framework for evaluating candidate monogenic lipodystrophy syndromes is suggested, based on the strength of human phenotypic, genetic, and biological evidence. Primacy was assigned to direct evidence from affected individuals, with genetic and biological evidence considered supportive but not determinative. This approach accommodates both the variable penetrance and expressivity characteristic of many lipodystrophy syndromes and potential discrepancies between human observations and experimental models. Although the proposed definition is applicable across all forms of lipodystrophy, the classification system described here is restricted to monogenic disorders. Together, these tools aim to improve clinical recognition, promote diagnostic consistency, and provide a robust and adaptable framework for evaluating emerging gene–disease associations in lipodystrophy.
- Open Access
- 2 December 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1687596
Management and outcomes in pregnant patients with monogenic diabetes due to pathogenic variants in GCK and HNF1A genes
Background: While treatment algorithms for the most common forms of monogenic diabetes (MD) are well established, managing affected pregnancies remains a clinical challenge. This study aimed to evaluate the clinical management and pregnancy outcomes in patients with the two prevalent MD subtypes: GCK and HNF1A. Methods: We analyzed 36 pregnancies from 27 patients: 18 pregnancies occurred in the context of 14 patients with GCK-hyperglycemia, and 18 pregnancies in 13 patients with HNF1A-MD. Patients’ characteristics, mode of treatment, glycemic control assessed by HbA1c, glycemia and pregnancy outcomes were evaluated. Results: The mean age of participants was 31.64 ± 3.91 years, similar between groups. Time from the diagnosis of diabetes was longer in subtypes HNF1A-MD (8.00 ± 6.20 vs. 3.46 ± 4.05 years, p=0.046). Preconception BMI and HbA1c were similar between groups. HbA1c during pregnancy was within recommended limits but significantly lower in the HNF1A group during the second trimester (33.2 ± 6.0 vs 38.0 ± 6 mmol/mol, p=0.032). Mean fasting glucose was higher in the GCK-hyperglycemia group in the first trimester (5.6 ± 0.8 vs. 4.9 ± 1.4 mmol/l, p=0.044). Before pregnancy diet therapy predominated in GCK-hyperglycemia (56.0% vs 0%, p<0.001), while insulin therapy was more frequent in HNF1A-MD (67.0% vs. 17.0%, p=0.006). All patients were switched to insulin therapy during pregnancy. Incidences of miscarriages were limited to 2 cases in HNF1A-MD; 1 case of prolonged neonatal hypoglycemia occurred in GCK-hyperglycemia. Maternal and neonatal outcomes were generally favorable. Conclusions: Pregnancy outcomes in patients with subtypes of monogenic diabetes: GCK-hyperglycemia and HNF1A were comparable and generally favorable. Individualized insulin therapy, regular monitoring and structured outpatient care support safe management even without fetal genotyping, though universal insulin in GCK subtypes diverges from emerging genotype-based practice.
- 2 December 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1687596
Open AccessManagement and outcomes in pregnant patients with monogenic diabetes due to pathogenic variants in GCK and HNF1A genes
Background: While treatment algorithms for the most common forms of monogenic diabetes (MD) are well established, managing affected pregnancies remains a clinical challenge. This study aimed to evaluate the clinical management and pregnancy outcomes in patients with the two prevalent MD subtypes: GCK and HNF1A. Methods: We analyzed 36 pregnancies from 27 patients: 18 pregnancies occurred in the context of 14 patients with GCK-hyperglycemia, and 18 pregnancies in 13 patients with HNF1A-MD. Patients’ characteristics, mode of treatment, glycemic control assessed by HbA1c, glycemia and pregnancy outcomes were evaluated. Results: The mean age of participants was 31.64 ± 3.91 years, similar between groups. Time from the diagnosis of diabetes was longer in subtypes HNF1A-MD (8.00 ± 6.20 vs. 3.46 ± 4.05 years, p=0.046). Preconception BMI and HbA1c were similar between groups. HbA1c during pregnancy was within recommended limits but significantly lower in the HNF1A group during the second trimester (33.2 ± 6.0 vs 38.0 ± 6 mmol/mol, p=0.032). Mean fasting glucose was higher in the GCK-hyperglycemia group in the first trimester (5.6 ± 0.8 vs. 4.9 ± 1.4 mmol/l, p=0.044). Before pregnancy diet therapy predominated in GCK-hyperglycemia (56.0% vs 0%, p<0.001), while insulin therapy was more frequent in HNF1A-MD (67.0% vs. 17.0%, p=0.006). All patients were switched to insulin therapy during pregnancy. Incidences of miscarriages were limited to 2 cases in HNF1A-MD; 1 case of prolonged neonatal hypoglycemia occurred in GCK-hyperglycemia. Maternal and neonatal outcomes were generally favorable. Conclusions: Pregnancy outcomes in patients with subtypes of monogenic diabetes: GCK-hyperglycemia and HNF1A were comparable and generally favorable. Individualized insulin therapy, regular monitoring and structured outpatient care support safe management even without fetal genotyping, though universal insulin in GCK subtypes diverges from emerging genotype-based practice.
- Open Access
- 26 March 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-13
Medical education in Poland: a descriptive analysis of legislative changes broadening the range of institutions eligible to conduct medical degree programmes
The expansion of medical schools is one of the proposed solutions to shortages in health workforces. Poland has been struggling with limited human resources in healthcare for years. The aim of the study was to provide an analysis of the current situation of medical education in Poland and to describe the impact of the government’s ongoing measures to provide a new influx of doctors. A retrospective, cross-sectional study presents a descriptive and comparative analysis of official governmental documents, showing the latest legal amendments, changes in admission limits, and geographical distribution of Higher Educational Institutions (HEIs) for the period of 2013–2023. We referenced the current number of physicians in each voivodship and used a dynamic index to analyse the changes in quotas. We performed statistical tests where needed, considering a p-value < 0.05 to be statistically significant. The latest legislative changes enabled occupational HEIs to offer MD programmes. The mean distance between the two nearest HEIs decreased between 2013 and 2023. Total admission limits increased by 92.3%, reaching 10,289 available spots in 2023. The dynamic index was higher for quotas in private HEIs than in public institutions. The index was comparable, regardless of the teaching language. The number of students positively correlated with the number of physicians working in each voivodship. This study highlights the uncontrolled expansion of medical education in Poland, driven by workforce demands but lacking a long-term strategy. Legislative inconsistencies hinder regulation, while new medical schools in rural areas may improve regional healthcare if properly planned. Recent policy changes emphasize the need for a national strategy based on demographic data and healthcare needs. Strengthening accreditation and quality control is crucial for sustainable medical education reform.
- 26 March 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-13
Open AccessMedical education in Poland: a descriptive analysis of legislative changes broadening the range of institutions eligible to conduct medical degree programmes
The expansion of medical schools is one of the proposed solutions to shortages in health workforces. Poland has been struggling with limited human resources in healthcare for years. The aim of the study was to provide an analysis of the current situation of medical education in Poland and to describe the impact of the government’s ongoing measures to provide a new influx of doctors. A retrospective, cross-sectional study presents a descriptive and comparative analysis of official governmental documents, showing the latest legal amendments, changes in admission limits, and geographical distribution of Higher Educational Institutions (HEIs) for the period of 2013–2023. We referenced the current number of physicians in each voivodship and used a dynamic index to analyse the changes in quotas. We performed statistical tests where needed, considering a p-value < 0.05 to be statistically significant. The latest legislative changes enabled occupational HEIs to offer MD programmes. The mean distance between the two nearest HEIs decreased between 2013 and 2023. Total admission limits increased by 92.3%, reaching 10,289 available spots in 2023. The dynamic index was higher for quotas in private HEIs than in public institutions. The index was comparable, regardless of the teaching language. The number of students positively correlated with the number of physicians working in each voivodship. This study highlights the uncontrolled expansion of medical education in Poland, driven by workforce demands but lacking a long-term strategy. Legislative inconsistencies hinder regulation, while new medical schools in rural areas may improve regional healthcare if properly planned. Recent policy changes emphasize the need for a national strategy based on demographic data and healthcare needs. Strengthening accreditation and quality control is crucial for sustainable medical education reform.
- Open Access
- 23 December 2024
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 51 (12) , 277
Gestational Diabetes and Type 1 Diabetes Affects Gustatory Sense but not Saccadic Eye Movements—A Prospective Cohort Study
Background: Nutritional therapy is the basis of diabetes treatment. Non-compliance with dietary recommendations is a common obstacle in the treatment of diabetes, with attenuated taste perception being one of many potential responsible factors. We investigated the impact of gestational diabetes mellitus (GDM) and type 1 diabetes (T1D) on two sensory modalities—saccadic eye movement and gustatory sense. Methods: In this prospective cohort study, we included 91 participants—28 women with GDM, 26 nonpregnant women with T1D and 37 non-diabetic non-pregnant women. We performed gustatory sense examination (GSE) with test strips for taste modalities and saccadic eye movement examination (SEME) and compared obtained results between study groups. This study was started prior to the requirement for registration of interventional cohort studies. Results: The mean age of participants was 29.4 ± 5.2 years. Women from the GDM group were older (31.0 [interquartile ranges (IQR): 29.0–35.8] vs. 28.0 [IQR: 22.5–34.8] and 28.0 [IQR: 25.3–30.0] years, p = 0.003) and had higher pre-pregnancy body mass index (BMI) compared to women with T1D and controls (26.2 [IQR: 20.8–28.5] vs. 22.6 [IQR: 20.9–24.4] and 20.9 [IQR: 19.1–22.3] kg/m2, p = 0.001). The total gustatory score was lower in women with GDM and T1D than controls with no significant difference between the GDM and T1D groups (68.8% [56.3%–75.0%], 67.5% [55.0%–76.3%], and 80.0% [70.0%–85.0%], respectively, p < 0.001). Saccadic latency was borderline higher in GDM than in the control group (189.5 ms [162.8–214.3] vs. 167.5 ms [154.5–186.3], p = 0.054) and duration was shorter in GDM than in T1D group (50.0 ms [47.0–53.0] vs. 54.5 ms [48.0–60.3], p = 0.041), with no differences in saccadic amplitude, mean and peak velocity between the studied groups. Conclusions: The gustatory sense was attenuated to a similar degree in nonpregnant women with T1D and those with GDM, when compared to non-diabetic non-pregnant women. This partially explains the phenomenon of cravings and affects compliance to dietary recommendations. Gustatory testing could be a potential measure to improve the metabolic control of diabetes and reducing the risk of maternal and neonatal complications of pregnancy. More studies in diverse populations of T1D patients are needed to assess the effectiveness of saccadometry in screening for diabetic neuropathy.
- 23 December 2024
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 51 (12) , 277
Open AccessGestational Diabetes and Type 1 Diabetes Affects Gustatory Sense but not Saccadic Eye Movements—A Prospective Cohort Study
Background: Nutritional therapy is the basis of diabetes treatment. Non-compliance with dietary recommendations is a common obstacle in the treatment of diabetes, with attenuated taste perception being one of many potential responsible factors. We investigated the impact of gestational diabetes mellitus (GDM) and type 1 diabetes (T1D) on two sensory modalities—saccadic eye movement and gustatory sense. Methods: In this prospective cohort study, we included 91 participants—28 women with GDM, 26 nonpregnant women with T1D and 37 non-diabetic non-pregnant women. We performed gustatory sense examination (GSE) with test strips for taste modalities and saccadic eye movement examination (SEME) and compared obtained results between study groups. This study was started prior to the requirement for registration of interventional cohort studies. Results: The mean age of participants was 29.4 ± 5.2 years. Women from the GDM group were older (31.0 [interquartile ranges (IQR): 29.0–35.8] vs. 28.0 [IQR: 22.5–34.8] and 28.0 [IQR: 25.3–30.0] years, p = 0.003) and had higher pre-pregnancy body mass index (BMI) compared to women with T1D and controls (26.2 [IQR: 20.8–28.5] vs. 22.6 [IQR: 20.9–24.4] and 20.9 [IQR: 19.1–22.3] kg/m2, p = 0.001). The total gustatory score was lower in women with GDM and T1D than controls with no significant difference between the GDM and T1D groups (68.8% [56.3%–75.0%], 67.5% [55.0%–76.3%], and 80.0% [70.0%–85.0%], respectively, p < 0.001). Saccadic latency was borderline higher in GDM than in the control group (189.5 ms [162.8–214.3] vs. 167.5 ms [154.5–186.3], p = 0.054) and duration was shorter in GDM than in T1D group (50.0 ms [47.0–53.0] vs. 54.5 ms [48.0–60.3], p = 0.041), with no differences in saccadic amplitude, mean and peak velocity between the studied groups. Conclusions: The gustatory sense was attenuated to a similar degree in nonpregnant women with T1D and those with GDM, when compared to non-diabetic non-pregnant women. This partially explains the phenomenon of cravings and affects compliance to dietary recommendations. Gustatory testing could be a potential measure to improve the metabolic control of diabetes and reducing the risk of maternal and neonatal complications of pregnancy. More studies in diverse populations of T1D patients are needed to assess the effectiveness of saccadometry in screening for diabetic neuropathy.
- Open Access
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1395424
Course of pregnancy and 10-year observation of twins diagnosed with GCK-MODY in the neonatal period: a case report
Monogenic diabetes accounts for 5% of all incidence of hyperglycemia and Maturity Onset Diabetes of the Young (MODY) is the most common form. In GCK-MODY, one of the most common forms of MODY, hyperglycemia is caused by a mutation of a gene responsible for coding glucokinase. At the clinical level, this condition presents as persistent, moderate and asymptomatic elevated fasting glucose levels and has a relatively low incidence of micro and macro-vascular complications. In general, the treatment of choice is to follow and maintain a healthy lifestyle. The incidence of GCK-MODY during pregnancy is 2% on average (0-6%). In this report, we introduce a case of a woman diagnosed with GCK-MODY during the pregnancy with twins, a boy and a girl, diagnosed with GCK-MODY after birth. We discuss the course of pregnancy, the need for access to fast and uncomplicated genetic diagnostics in utero, and the impact of the MODY diagnosis on the life of the mother and that of her children. In our case, the diagnosis of GCK-MODY was associated with a feeling of relief, after years of uncertainty, and helped to introduce more appropriate eating behaviors and lifestyle changes for both the mother and her children.
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1395424
Open AccessCourse of pregnancy and 10-year observation of twins diagnosed with GCK-MODY in the neonatal period: a case report
Monogenic diabetes accounts for 5% of all incidence of hyperglycemia and Maturity Onset Diabetes of the Young (MODY) is the most common form. In GCK-MODY, one of the most common forms of MODY, hyperglycemia is caused by a mutation of a gene responsible for coding glucokinase. At the clinical level, this condition presents as persistent, moderate and asymptomatic elevated fasting glucose levels and has a relatively low incidence of micro and macro-vascular complications. In general, the treatment of choice is to follow and maintain a healthy lifestyle. The incidence of GCK-MODY during pregnancy is 2% on average (0-6%). In this report, we introduce a case of a woman diagnosed with GCK-MODY during the pregnancy with twins, a boy and a girl, diagnosed with GCK-MODY after birth. We discuss the course of pregnancy, the need for access to fast and uncomplicated genetic diagnostics in utero, and the impact of the MODY diagnosis on the life of the mother and that of her children. In our case, the diagnosis of GCK-MODY was associated with a feeling of relief, after years of uncertainty, and helped to introduce more appropriate eating behaviors and lifestyle changes for both the mother and her children.
- Open Access
- 23 April 2024
- Published by VM Media Group sp. z o.o in Ginekologia Polska
Tight versus less tight 1-hour postprandial glycemic target in women with gestational diabetes mellitus — a single-center cohort study
Objectives: We aimed to assess the impact of the change of 1-hour postprandial glycemic target from < 6.7 mmol/L (120 mg/dL) to < 7.8 mmol/L (140 mg/dL) on gestational diabetes mellitus (GDM) treatment and pregnancy outcomes. Material and methods: In a retrospective analysis of 1021 GDM patients from the Department of Metabolic Diseases, University Hospital in Cracow, Poland, we compared insulin therapy regimens and pregnancy outcomes between women admitted in 2014–2016 (before the change) and in 2018–2019 (after it). Results: A total of 377 patients were admitted between 2014 and 2016 (TIGHT group) and 644 between 2018 and 2019 (LESS TIGHT group). Women from the LESS TIGHT group were older (32 vs 30 years, p < 0.001) and gained less weight during pregnancy (7.0 vs 9.0 kg, p < 0.001). There was no change in the frequency of any insulin therapy (51.6% vs 56.1%, p = 0.168). In the LESS TIGHT group, the basal insulin-only model was used more frequently (32.5% vs 10.2%, p < 0.001), while the prandial insulin and basal-bolus model less frequently (23.6% vs 42.6% and 21.4% vs 36.7%, p < 0.001, respectively) than in the TIGHT group. There were no differences in the frequency of cesarean sections, preterm births, Hbd of delivery, mean birth weight or prevalence of perinatal complications. Conclusions: Less tight glycemic targets in women with GDM, compared to tighter targets, were associated with less frequent use of prandial insulin, with insulin therapy often limited to basal administration. The change in glycemic targets did not affect the prevalence of adverse pregnancy outcomes, providing evidence supporting new recommendations. Keywords: gestational diabetes mellitus GDM glycemic targets pregnancy outcomes insulin therapy
- 23 April 2024
- Published by VM Media Group sp. z o.o in Ginekologia Polska
Open AccessTight versus less tight 1-hour postprandial glycemic target in women with gestational diabetes mellitus — a single-center cohort study
Objectives: We aimed to assess the impact of the change of 1-hour postprandial glycemic target from < 6.7 mmol/L (120 mg/dL) to < 7.8 mmol/L (140 mg/dL) on gestational diabetes mellitus (GDM) treatment and pregnancy outcomes. Material and methods: In a retrospective analysis of 1021 GDM patients from the Department of Metabolic Diseases, University Hospital in Cracow, Poland, we compared insulin therapy regimens and pregnancy outcomes between women admitted in 2014–2016 (before the change) and in 2018–2019 (after it). Results: A total of 377 patients were admitted between 2014 and 2016 (TIGHT group) and 644 between 2018 and 2019 (LESS TIGHT group). Women from the LESS TIGHT group were older (32 vs 30 years, p < 0.001) and gained less weight during pregnancy (7.0 vs 9.0 kg, p < 0.001). There was no change in the frequency of any insulin therapy (51.6% vs 56.1%, p = 0.168). In the LESS TIGHT group, the basal insulin-only model was used more frequently (32.5% vs 10.2%, p < 0.001), while the prandial insulin and basal-bolus model less frequently (23.6% vs 42.6% and 21.4% vs 36.7%, p < 0.001, respectively) than in the TIGHT group. There were no differences in the frequency of cesarean sections, preterm births, Hbd of delivery, mean birth weight or prevalence of perinatal complications. Conclusions: Less tight glycemic targets in women with GDM, compared to tighter targets, were associated with less frequent use of prandial insulin, with insulin therapy often limited to basal administration. The change in glycemic targets did not affect the prevalence of adverse pregnancy outcomes, providing evidence supporting new recommendations. Keywords: gestational diabetes mellitus GDM glycemic targets pregnancy outcomes insulin therapy
- Open Access
- 1 October 2023
- Published by SAGE Publications in Sage Open
- Vol. 13 (4)
Non-technical Skills in Cardiopulmonary Resuscitation: Improvement and Evaluation of a New Course Introduced to the Curriculum at a Medical School in Poland in 2018 to 2019
Non-technical skills (NTS) are important skills in emergency medicine and should be a necessity even at the stage of medical studies. The aim of this study was to assess how increasing the number of non-technical skills hours influenced the results of non-technical competences among medical students. In this investigation, 296 Polish medical students in the sixth year at Medical College in Krakow, Poland were included in the study. The students were divided into two research groups: I in 2018 and II in 2019. The groups differed in the number of total hours that focused on non-technical skills, in 2018: 60 hr, and 2019: 120 total hours. Non-technical competencies were assessed at the Crisis Resource Management station using sudden cardiac arrest scenarios. In 2018, the median was 20 points and the average of the points obtained in this group was 19.53 points (SD 5.39 points). In 2019, the median was 26 points and the average of points was 25.07 points (SD 5.23 points). Students who had more non-technical skills classes (120 hr) scored more points on the OSCE exam than group I (60 hr) ( p < .001). The median of points in non-technical competences depended on the number of teaching hours in which the main emphasis was on the development of these skills. This investigation demonstrates that more teaching hours dedicated to improving the non-technical skills of students corresponded to better results on the cardiopulmonary resuscitation scenarios.
- 1 October 2023
- Published by SAGE Publications in Sage Open
- Vol. 13 (4)
Open AccessNon-technical Skills in Cardiopulmonary Resuscitation: Improvement and Evaluation of a New Course Introduced to the Curriculum at a Medical School in Poland in 2018 to 2019
Non-technical skills (NTS) are important skills in emergency medicine and should be a necessity even at the stage of medical studies. The aim of this study was to assess how increasing the number of non-technical skills hours influenced the results of non-technical competences among medical students. In this investigation, 296 Polish medical students in the sixth year at Medical College in Krakow, Poland were included in the study. The students were divided into two research groups: I in 2018 and II in 2019. The groups differed in the number of total hours that focused on non-technical skills, in 2018: 60 hr, and 2019: 120 total hours. Non-technical competencies were assessed at the Crisis Resource Management station using sudden cardiac arrest scenarios. In 2018, the median was 20 points and the average of the points obtained in this group was 19.53 points (SD 5.39 points). In 2019, the median was 26 points and the average of points was 25.07 points (SD 5.23 points). Students who had more non-technical skills classes (120 hr) scored more points on the OSCE exam than group I (60 hr) ( p < .001). The median of points in non-technical competences depended on the number of teaching hours in which the main emphasis was on the development of these skills. This investigation demonstrates that more teaching hours dedicated to improving the non-technical skills of students corresponded to better results on the cardiopulmonary resuscitation scenarios.
- Open Access
- 21 August 2023
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 44 (S1) , 61-68
The effectiveness of selected temporary testing protocols for gestational diabetes during the COVID-19 pandemic
Objective: During the COVID-19 pandemic, the screening approach to the diagnosis of gestational diabetes mellitus (GDM) was subject to emergency simplifications. We aimed at assessing the effectiveness of two of these temporary pandemic protocols—namely the Australian and UK, and to examine the insights they gave into the effectiveness of the more standard WHO-outlined GDM diagnosis protocol. Methods: We performed a retrospective analysis of 432 GDM patients attending the outpatient clinic at the University Hospital of Cracow, Poland throughout 2020. Results: When applying the UK criteria, 272 (63.0%) of 432 GDM cases would be missed. Women with missed-GDM by UK criteria were slightly older, had lower BMI, and had lower use of insulin. The frequency of child perinatal complications was lower in the missed GDM group (7.6% vs. 18.9%, p = 0.042) when compared to the non-missed cases group. When applying the Australian criteria, 86 of 432 (19.9%) GDM cases would be missed. Women with missed-GDM by the Australian criteria had lower BMI and less commonly used insulin than the women not missed. There were no differences in the frequency of child and maternal complications. Conclusions: Modifications proposed from the UK and Australia resulted in varying decreases and delays in GDM diagnoses, but with no apparent harm to mothers and offspring. More studies are required to investigate the impact of the simplification of GDM diagnosis on pregnancy outcomes.
- 21 August 2023
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 44 (S1) , 61-68
Open AccessThe effectiveness of selected temporary testing protocols for gestational diabetes during the COVID-19 pandemic
Objective: During the COVID-19 pandemic, the screening approach to the diagnosis of gestational diabetes mellitus (GDM) was subject to emergency simplifications. We aimed at assessing the effectiveness of two of these temporary pandemic protocols—namely the Australian and UK, and to examine the insights they gave into the effectiveness of the more standard WHO-outlined GDM diagnosis protocol. Methods: We performed a retrospective analysis of 432 GDM patients attending the outpatient clinic at the University Hospital of Cracow, Poland throughout 2020. Results: When applying the UK criteria, 272 (63.0%) of 432 GDM cases would be missed. Women with missed-GDM by UK criteria were slightly older, had lower BMI, and had lower use of insulin. The frequency of child perinatal complications was lower in the missed GDM group (7.6% vs. 18.9%, p = 0.042) when compared to the non-missed cases group. When applying the Australian criteria, 86 of 432 (19.9%) GDM cases would be missed. Women with missed-GDM by the Australian criteria had lower BMI and less commonly used insulin than the women not missed. There were no differences in the frequency of child and maternal complications. Conclusions: Modifications proposed from the UK and Australia resulted in varying decreases and delays in GDM diagnoses, but with no apparent harm to mothers and offspring. More studies are required to investigate the impact of the simplification of GDM diagnosis on pregnancy outcomes.
- 19 July 2022
- Published by Wiley in Oral Science International
- Vol. 20 (2) , 67-77
Inflammatory markers in pregnant women with periodontal diseases—Systematic review and network meta‐analysis
Periodontal diseases (PD) have been associated with adverse pregnancy outcomes. Several studies reported on cytokines concentrations and oxidative stress in periodontal patients during pregnancy. We aimed at reviewing systemic inflammatory markers concentrations and oxidative stress status in the serum of pregnant women with periodontal diseases (PD) and gestational diabetes mellitus (GDM). In this systematic review and network meta‐analysis, 5595 studies were screened. In the non‐GDM arm of 48 reviewed articles, 11 were included: six for CRP, two for TNF‐alpha, and three for total antioxidant capacity (TAOC). CRP and TNF‐alpha were higher in PD groups in comparison with healthy periodontum group; however, the differences were not statistically significant, whereas TAOC was lower in PD group. In the GDM arm of eight articles, two were included: one for CRP and one for adiponectin and leptin, which was insufficient for further analysis. The evidence for differences in the concentrations of inflammatory markers in pregnant women with PD and with healthy periodontum is limited, mainly due to confounding factors such as varying PD diagnostic criteria and methodology of assessing cytokine levels. However, these results may suggest a particular trend toward an attenuated inflammatory response in pregnant periodontal patients. There still exists a paucity of data on the subject.
- 19 July 2022
- Published by Wiley in Oral Science International
- Vol. 20 (2) , 67-77
Inflammatory markers in pregnant women with periodontal diseases—Systematic review and network meta‐analysis
Periodontal diseases (PD) have been associated with adverse pregnancy outcomes. Several studies reported on cytokines concentrations and oxidative stress in periodontal patients during pregnancy. We aimed at reviewing systemic inflammatory markers concentrations and oxidative stress status in the serum of pregnant women with periodontal diseases (PD) and gestational diabetes mellitus (GDM). In this systematic review and network meta‐analysis, 5595 studies were screened. In the non‐GDM arm of 48 reviewed articles, 11 were included: six for CRP, two for TNF‐alpha, and three for total antioxidant capacity (TAOC). CRP and TNF‐alpha were higher in PD groups in comparison with healthy periodontum group; however, the differences were not statistically significant, whereas TAOC was lower in PD group. In the GDM arm of eight articles, two were included: one for CRP and one for adiponectin and leptin, which was insufficient for further analysis. The evidence for differences in the concentrations of inflammatory markers in pregnant women with PD and with healthy periodontum is limited, mainly due to confounding factors such as varying PD diagnostic criteria and methodology of assessing cytokine levels. However, these results may suggest a particular trend toward an attenuated inflammatory response in pregnant periodontal patients. There still exists a paucity of data on the subject.